Crossmark

Thromboembolic events associated with antiangiogenic monoclonal antibodies: a disproportionality analysis from FDA adverse event reporting system (FAERS) database

Crossref DOI link: https://doi.org/10.1186/s12959-026-00829-w

Published Online: 2026-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Hong

Su, Yanzhao

Song, Jianrong

Zhen, Lan
Funding

Funding for this research was provided by:

Natural Science Foundation of Fujian Province of China (2024J08264)

Joint Funds for the Innovation of Science and Technology, Fujian Province (2024Y9567)
License Information

Text and Data Mining valid from 2026-01-17

Version of Record valid from 2026-02-11
More Information

Article History

Received: 5 February 2025

Accepted: 12 January 2026

First Online: 17 January 2026

Declarations

:

: Since the FAERS database is publicly available and patient information is anonymized and de-identified, it does not involve informed consent or ethical approval.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below